Samsung Medical Center
Lymphoma treatment cost in Republic of Korea typically runs from $1,100 to $2,400 for chemotherapy courses, while a consultation with a hematologist ranges from $28 to $40. For advanced cases, bone marrow transplantation runs from $1,500 to $138,500. Total expenses depend on the lymphoma subtype, disease stage, and hospital stay duration. Patients can save approximately 30-50% compared to US costs. Seoul and Incheon are the primary medical hubs.
Typical Lymphoma Treatment Costs in Republic of Korea
Bookimed Expert Insight: For complex cases, choosing centers with presidential standards or the highest cancer treatment statistics is essential. Seoul National University Hospital (SNUH) is known for the country's highest cancer treatment success rates. Patients requiring multidisciplinary care should consider Asan Medical Center, South Korea’s largest medical facility. Digital infrastructure at Seoul National University Bundang Hospital (SNUBH) enhances diagnostic accuracy for refractory lymphoma. For female patients, Ewha Womans University Medical Center offers specialized oncology environments with JCI accreditation.
| Republic of Korea | Turkey | Austria | |
| Chemotherapy for breast cancer | from $2,200 | from $1,200 | from $15,000 |
| Chemotherapy | from $1,060 | from $3,000 | from $2,500 |
| Bone marrow transplantation | from $1,500 | from $27,500 | from $140,000 |
| Radiation therapy for colorectal cancer | - | from $7,000 | from $12,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Lymphoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Lymphoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Lymphoma treatment journey.
Prof. Keun Chil Park, MD is a hematologist-oncologist who graduated from Seoul National University College of Medicine. He specializes in lung, head and neck, and esophageal cancer and is a member of multiple professional organizations, including the Korean Medical Association, the Korean Association of Internal Medicine, the Korean Cancer Association, the American Society of Clinical Oncology, the American Association for Cancer Research, the European Society of Medical Oncology, the International Association for the Study of Lung Cancer, and the Korean Association for Clinical Oncology.
Written by Anna Leonova
Written by Halina Shubala